Analysis of Healthcare Resource Utilization and Costs after the Initiation of Biologic Treatment in Patients with Ulcerative Colitis and Crohn’s Disease
**Background:** This retrospective cohort study aimed to describe and quantify healthcare resource utilization and costs for patients with ulcerative colitis (UC) and Crohn’s disease (CD) following initiation of biologic therapy. **Methods:** Resource utilization and costs were analyzed at baseline...
Saved in:
Main Authors: | Sue Perera, Shibing Yang, Marni Stott-Miller, Joanne Brady |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2018-09-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9791 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Colonic cytokines for severe ulcerative colitis
by: Ye. A. Konovich, et al.
Published: (2016-08-01) -
Mesalazine use tactics in the ulcerative colitis patients
by: A. V. Korolev, et al.
Published: (2013-03-01) -
Efficacy of mesalazine at ulcerative colitis with nutritional failure
by: A. V. Korolyov, et al.
Published: (2015-03-01) -
Serum cytokines in ulcerative colitis of various clinical activity
by: Ye. A. Konovich, et al.
Published: (2014-10-01) -
Prevalence of Erosive-ulcerative Lesions of the Stomach and Helicobacter Pylori Infection in Patients with Ulcerative Colitis
by: N. A. Ponkratova, et al.
Published: (2019-06-01)